CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-03 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,414 | 40,830 | ||
| 2018-12-03 | Mills Kenneth T. President and CEO | Sale | −18,700 | $60.34 | $1.1M | 232,300 |
| 2018-12-03 | Mills Kenneth T. President and CEO | Sale | −1,300 | $61.33 | $80K | 231,000 |
| 2018-11-30 | Danos Olivier Chief Scientific Officer | Exercise or conversion | +1,500 | $20.35 | $31K | 1,500 |
| 2018-11-30 | Danos Olivier Chief Scientific Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 78,500 | ||
| 2018-11-29 | BESHAR LUKE M Director | Exercise or conversion | +12,784 | $3.76 | $48K | 12,784 |
| 2018-11-29 | BESHAR LUKE M Director | Sale | −12,784 | $65.00 | $831K | 0 |
| 2018-11-29 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −12,784 | 53,000 | ||
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion | +883 | $49.45 | $44K | 883 |
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion | +4,687 | $22.00 | $103K | 5,570 |
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion | +6,250 | $18.85 | $118K | 11,820 |
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion | +6,250 | $12.74 | $80K | 18,070 |
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion | +716 | $3.76 | $3K | 18,786 |
| 2018-11-27 | BESHAR LUKE M Director | Sale | −18,786 | $65.03 | $1.2M | 0 |
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −883 | 7,292 | ||
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −4,687 | 0 | ||
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −6,250 | 0 | ||
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −6,250 | 0 | ||
| 2018-11-27 | BESHAR LUKE M Director | Exercise or conversion · Stock Option (Right to Buy) | −716 | 65,784 | ||
| 2018-11-26 | BESHAR LUKE M Director | Exercise or conversion | +1,721 | $49.45 | $85K | 1,721 |
Page 32 of 43 · 852 trades